Salient Bio

News

UK diagnostics firm Salient Bio has launched a robotics-driven COVID-19 mass testing platform after spinning out from Imperial College.

News

UK start-up Potential Sciences emerged from stealth today with a sizeable seed funding round and an ambition to transform drug discovery with AI.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.